What does Takeda Pharmaceuticals Australia Pty Ltd do for the Australian Government?
Takeda Pharmaceuticals Australia Pty Ltd is an Australian Government contractor with 4 contracts worth $596.1M since 2020. Their largest government client is National Blood Authority, and their average contract value is $149.0M.
Key Metrics
4Total Contracts
$596.1MTotal Value
1Agencies Served
$149.0MAvg Contract
6Years Active
How much does Takeda Pharmaceuticals Australia Pty Ltd win in government contracts each year?
View data table
| Year | Contracts | Value |
|---|---|---|
| 2020 | 1 | $109.5M |
| 2021 | 1 | $434.1M |
| 2022 | 1 | $30.2M |
| 2025 | 1 | $22.3M |
Who are Takeda Pharmaceuticals Australia Pty Ltd's biggest government clients?
| Agency | Contracts | Value | Share |
|---|---|---|---|
| National Blood Authority | 4 | $596.1M | 100.0% |
How does Takeda Pharmaceuticals Australia Pty Ltd win government contracts?
| Method | Contracts | Value | Share |
|---|---|---|---|
| limited | 3 | $573.8M | 75.0% |
| open | 1 | $22.3M | 25.0% |
What are Takeda Pharmaceuticals Australia Pty Ltd's largest government contracts?
| Contract | Agency | Value | Awarded |
|---|---|---|---|
| National Supply arrangement for imported immunoglobulin products | National Blood Authority | $434.1M | |
| Supply of Advate and Adynovate Imported Plasma and Recombinant Products | National Blood Authority | $109.5M | |
| Imported Plasma and Recombinant Products | National Blood Authority | $30.2M | |
| Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate | National Blood Authority | $22.3M |
What are Takeda Pharmaceuticals Australia Pty Ltd's most recent government contracts?
| Contract | Agency | Value | Date |
|---|---|---|---|
| Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate | National Blood Authority | $22.3M | |
| Imported Plasma and Recombinant Products | National Blood Authority | $30.2M | |
| National Supply arrangement for imported immunoglobulin products | National Blood Authority | $434.1M | |
| Supply of Advate and Adynovate Imported Plasma and Recombinant Products | National Blood Authority | $109.5M |
Who competes with Takeda Pharmaceuticals Australia Pty Ltd for government contracts?
Other suppliers winning contracts from the same government agencies.
| Supplier | Contracts | Value |
|---|---|---|
| Australian Red Cross Society | 2 | $16.81B |
| CSL Behring (Australia) Pty Ltd | 8 | $6.32B |
| Grifols Australia | 28 | $1.25B |
| Roche Products Pty Ltd | 2 | $670.9M |
| Novo Nordisk Pharmaceuticals Pty Ltd | 3 | $585.5M |
| Octapharma Australia Pty Ltd | 2 | $549.0M |
| Pfizer Australia Pty Ltd | 3 | $523.1M |
| Baxter Healthcare Pty Ltd | 3 | $425.6M |
| Sanofi-Aventis Australia Pty Ltd | 2 | $243.4M |
| Bayer Australia Limited | 1 | $136.9M |
What is Takeda Pharmaceuticals Australia Pty Ltd's registered business information?
- Australian Business Number (ABN)
- 71095610870
- Registered Name
- Takeda Pharmaceuticals Australia Pty Ltd
- Government Contracting Period
- 2020 – 2025
Verify entity details on the Australian Business Register.
Procurement Categories
UNSPSC categories where Takeda Pharmaceuticals Australia Pty Ltd is active.
Track Takeda Pharmaceuticals Australia Pty Ltd's government contracts
Get alerts when new contracts are awarded, expiring contracts come up for recompete, and competitors win in your categories.
Start free — 5 searches includedNo credit card required. Scout plans from US$49/mo.
Explore more
View procurement map · Browse all suppliers · Search contracts · National Blood Authority profile